AI assistant
Sending…
Perspective Therapeutics, Inc. — Director's Dealing 2007
Sep 13, 2007
33510_dirs_2007-09-13_667e1651-5236-44d9-8fc9-0b085501bcb7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2006-08-15
Reporting Person: Swanberg David (Director, EVP Operations & Secretary)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2006-08-15 | stock options (right to buy) | $3.11 | A | 20000 | Acquired | 2016-08-15 | common stock (20000) | Indirect |
Footnotes
F1: 6,666 stock options vest 8/15/2006, 6,667 stock options vest 8/15/2007, 6,667 stock options vest 8/15/2008.
F2: 20,000 stock options are held indirectly through Mr. Swanberg's spouse. The remaining 300,000 stock options are held directly.
More from Perspective Therapeutics, Inc.
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 21
Major Shareholding Notification
2026
May 12
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 4
Major Shareholding Notification
2026
Apr 27
Regulatory Filings
2026
Apr 20
Proxy Solicitation & Information Statement
2026
Apr 16
Proxy Solicitation & Information Statement
2026
Apr 16